Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies. Conference Paper uri icon

authors

  • Hong, David S
  • Schoffski, Patrick
  • Calvo, Aitana
  • Sarantopoulos, John
  • Ochoa De Olza, María
  • Carvajal, Richard D
  • Prawira, Amy
  • Kyi, Chrisann
  • Esaki, Taito
  • Akerley, Wallace L
  • De Braud, Filippo G
  • Hui, Rina
  • Zhang, Tian
  • Soo, Ross A
  • Maur, Michela
  • Weickhardt, Andrew James
  • Roy Chowdhury, Niladri
  • Sabatos-Peyton, Catherine
  • Kwak, Eunice Lee
  • Tan, Daniel Shao-Weng

publication date

  • May 20, 2018